Clinical Trial Update: Safety and Immunogenicity Study of GSK Biologicals Tuberculosis Vaccines (692342) to Healthy Adults [Phase 2]

View source ↗

Summary

Phase 2 safety and immunogenicity trial of GSK tuberculosis vaccines in healthy adults completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Tuberculosis vaccines

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2017-02-03